Align Technology (ALGN)
(Delayed Data from NSDQ)
$212.15 USD
+1.37 (0.65%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $211.69 -0.46 (-0.22%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$212.15 USD
+1.37 (0.65%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $211.69 -0.46 (-0.22%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum C VGM
Zacks News
Haemonetics Plasma Arm Advances, Blood Center Sluggish
by Zacks Equity Research
On Jul 13, we issued an updated research report on Haemonetics Corporation (HAE).
Why Is It the Perfect Time to Buy Thermo Fisher (TMO) Stock?
by Zacks Equity Research
Thermo Fisher Scientific, Inc. (TMO) is on a healthy growth trajectory of late and has rallied 17.7% over the past three months.
BioTelemetry (BEAT) Acquires LifeWatch for $280 Million
by Zacks Equity Research
BioTelemetry Inc. (BEAT) enhances its position in the wireless medicine space, enlarges product profile and customer base in cardiac monitoring and diagnostic services with LifeWatch buyout.
Hill-Rom (HRC) at 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of Batesville, IN-based Hill-Rom Holdings, Inc. (HRC) scaled a new 52-week high of $84.17 on Jul 14.
Avantor to Acquire VWR, Consolidation Promises Global Gains
by Zacks Equity Research
On Jul 14, we issued an updated research report on Radnor, PA-based VWR Corporation (VWR).
DaVita Medical Group Buys Dr. Rahn Shaw Practices in Orlando
by Zacks Equity Research
DaVita Inc. (DVA) recently acquired Dr. Rahn Shaw's practices, Park Avenue Medical, Inc. and Winter Park Health Center, Inc., each located in Orlando.
Abiomed (ABMD) Scores a Strong Buy Right Now: Here's How
by Zacks Equity Research
With solid growth prospects Abiomed (ABMD) carries a Zacks Rank #1 (Strong Buy) which is an attractive pick at present.
Medtronic Enrolls First Patient Under STOP AF First Trial
by Zacks Equity Research
Medtronic (MDT) recently announced the first enrollment to its STOP AF First clinical trial.
Zimmer Biomet's Preliminary Q2 Numbers Solid, CEO Steps Down
by Zacks Equity Research
Indiana-based Zimmer Biomet Holdings, Inc. (ZBH), a leading player in the global musculoskeletal space, recently announced second-quarter 2017 preliminary results.
Edwards Emerges Strong on FDA Nods, International Prospect
by Zacks Equity Research
On Jul 11, we issued an updated research report on the leading molecular diagnostic company, Edwards Lifesciences Corporation (EW).
Here's Why You Should Add ResMed to Your Portfolio Now
by Zacks Equity Research
California-based ResMed, Inc. (RMD) has been on a healthy growth trajectory of late.
CVS Health's MinuteClinic Joins EOHN for Workplace Healthcare
by Zacks Equity Research
MinuteClinic, the retail medical clinic of CVS Health Corporation (CVS), announced a tie-up with the Alere eScreen Occupational Health Network.
Express Scripts Rides High on Increased Generic Utilization
by Zacks Equity Research
On Jul 10, we issued an updated research report on St. Louis, MO-based pharmacy benefit manager Express Scripts Holding Company (ESRX).
PAREXEL (PRXL) Gets CEO Cancer Gold Standard Accreditation
by Zacks Equity Research
PAREXEL International Corporation (PRXL) was recently nominated as a CEO Cancer Gold Standard employer by CEO Roundtable on Cancer.
RTI Surgical at a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of RTI Surgical, Inc. (RTIX), based in Alachua, FL, scaled a new 52-week high of $6.00 on Jul 10, eventually closing a bit lower at $5.65.
Neogen Introduces Test for Listeria in Environmental Samples
by Zacks Equity Research
Neogen Corporation (NEOG) recently developed Listeria Right Now test system.
Myriad Genetics to Grow with Study Successes, New Alliances
by Zacks Equity Research
On Jul 6, we issued an updated research report on Myriad Genetics, Inc. (MYGN).
Investors Look for Gains as Abbott Labs Set to Acquire Alere
by Zacks Equity Research
On majority of Alere shareholders' recent approval in favor of the merger with Abbott (ABT), the deal is now expected to close by the end of third-quarter 2017.
ResMed Sees Potential in SDB Market, Eyes Global Growth
by Zacks Equity Research
On Jul 6, we issued an updated research report on San Diego, CA-based ResMed, Inc. (RMD).
Baxter and TAU Ink New Licensing Agreements through Ramot
by Zacks Equity Research
Baxter International (BAX) has recently teamed up with Tel Aviv University, Israel's largest research and teaching university (TAU), on two new licensing agreements through Ramot.
Edwards Lifesciences' INSPIRIS RESILIA Valve Wins FDA Nod
by Zacks Equity Research
Edwards Lifesciences Corporation (EW) recently announced the receipt of FDA approval for its INSPIRIS RESILIA aortic valve.
Will Walgreens Gain from Revised Rite Aid Agreement?
by Zacks Equity Research
The new agreement would enable Walgreens Boots Alliance (WBA) to buy nearly half of the Rite Aid business at a deal value, almost one-third of the original price.
Omnicell (OMCL) Rides on Acquisitions Amid Tough Competition
by Zacks Equity Research
On Jul 4, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).
Abbott Freestyle Libre System Gets Health Canada License
by Zacks Equity Research
Abbott Laboratories (ABT) recently announced the receipt of Health Canada license for its FreeStyle Libre Flash Glucose Monitoring System.
Here's Why You Can Buy Quest Diagnostics Stock Right Now
by Zacks Equity Research
Quest Diagnostics Incorporated (DGX) is on a healthy growth trajectory of late.